SANUWAVE Health Inc SNWV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.85
- Day Range
- $5.45–5.86
- 52-Week Range
- $3.92–36.42
- Bid/Ask
- $5.01 / $5.89
- Shares Outstanding
- 8.60M
- Market Cap
- $48.34M
- Volume/Avg
- 23,439 / 136,775
Key Statistics
- Price/Earnings (Normalized)
- 5.00
- Price/Sales
- 1.17
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 55
- Website
- https://www.sanuwave.com
Valuation
|
Metric
|
SNWV
|
|---|---|
Price/Earnings (Normalized) | 5.00 |
Price/Book Value | 17.35 |
Price/Sales | 1.17 |
Price/Cash Flow | 7.32 |
Price/Earnings
SNWV
Financial Strength
|
Metric
|
SNWV
|
|---|---|
Quick Ratio | 0.84 |
Current Ratio | 1.28 |
Interest Coverage | 5.02 |
Quick Ratio
SNWV
Profitability
|
Metric
|
SNWV
|
|---|---|
Return on Assets (Normalized) | 28.33% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 60.93% |
Return on Assets
SNWV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|yWzHxy | LOCK|>>tLz | $172B | |||
| Medtronic PLC
MDT
| LOCK|%!V@RC | LOCK|pr$C | $113B | |||
| Stryker Corp
SYK
| LOCK|h?nl#F^& | LOCK|^S | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|^%dGj>R | LOCK|?&?n | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|C$%$zh^$ | LOCK|?!!>! | $49B | |||
| DexCom Inc
DXCM
| LOCK|QT&?$&$@ | LOCK|>%x<> | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|XWbMpXb | LOCK|&q& | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|ng | LOCK|WW | $24B | |||
| Steris PLC
STE
| LOCK|qfNwkZ | LOCK|Tc<# | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|r%dR%kk! | LOCK|M^ | $17B |
United States